References
- 1. Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, et al. Coronavirus disease 2019—COVID-19. Clinical Microbiology Reviews. 2020;33: e00028-20.10.1128/CMR.00028-20
- 2. Gagneux S. Ecology and evolution of Mycobacterium tuberculosis. Nature Reviews Microbiology 2018;16: 202–213.10.1038/nrmicro.2018.8
- 3. Prasad R, Singh A, Gupta N. Tuberculosis and COVID-19 in India: Challenges and opportunities. Lung India. 2020;37(4): 292–294.10.4103/lungindia.lungindia_260_20
- 4. Stop TB Partnership. The potential impact of the covid-19 response on tuberculosis in high-burden countries: a modelling analysis. Available from: http://www.stoptb.org/assets/documents/news/Modeling%20Report_1%20May%202020_FINAL.pdf [Accessed 6th April 2021].
- 5. Hogan AB, Jewell BL, Sherrard-Smith E, Vesga JF, Watson OJ, Whittaker C, et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. The Lancet Global Health 2020;8: e1132–e1141.10.1016/S2214-109X(20)30288-6
- 6. Dookie N, Padayatchi N, Naidoo K. Tuberculosis elimination in the Era of COVID-19: a moving target. Clinical Infectious Diseases. 2020;ciaa1400. doi: 10.1093/cid/ciaa1400.10.1093/cid/ciaa1400754336432927477
- 7. Jain VK, Iyengar KP, Samy DA, Vaishya R. Tuberculosis in the era of COVID-19 in India. Diabetology & Metabolic Syndrome. 2020;14(5): 1439–1443.10.1016/j.dsx.2020.07.034738728732755848
- 8. Ronald LA, FitzGerald JM, Benedetti A, Boivin JF, Schwartzman K, Bartlett-Esquilant G, et al. Predictors of hospitalization of tuberculosis patients in Montreal, Canada: a retrospective cohort study. BMC Infectious Diseases. 2016;16(1): 679.10.1186/s12879-016-1997-x511123227846812
- 9. Bhargava A, Bhargava M. Tuberculosis deaths are predictable and preventable: comprehensive assessment and clinical care is the key. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2020;19: 1001552.10.1016/j.jctube.2020.100155708261032211519
- 10. Government of India. Central Tuberculosis Division. India TB report 2020. Available from: https://tbcindia.gov.in/ [Accessed 7th April 2021].
- 11. Taylor Z, Marks SM, Ríos Burrows NM, Weis SE, Stricof RL, Miller B. Causes and costs of hospitalization of tuberculosis patients in the United States. The International Journal of Tuberculosis and Lung Disease. 2000;4(10): 931–939.
- 12. Aparecida RA, Nemoto MT. Admission for tuberculosis to a university hospital. Pneumologia 2003;29(1): 9–14.10.1590/S0102-35862003000100004
- 13. The Global Fund. Global fund survey: majority of HIV, TB and malaria programs face disruptions as a result of COVID-19. 2020. Available from: https://www.theglobalfund.org/en/covid-19/news/2020-06-17-global-fund-survey-majority-of-hiv-tband-malaria-programs-face-disruptions-as-a-result-of-covid-19/ [Accessed 6th April 2020].
- 14. Crisan-Dabija R, Grigorescu C, Pavel CA, Artene B, Popa IV, Cernomaz A, et al. Tuberculosis and COVID-19: lessons from the past viral outbreaks and possible future outcomes. Canadian Respiratory Journal. 2020;2020: 1401053.10.1155/2020/1401053747947432934758
- 15. Walaza S, Cohen C, Tempia S, Moyes J, Nguweneza A, Madhi SA, et al. Influenza and tuberculosis co-infection: a systematic review. Influenza and Other Respiratory Viruses. 2020;14(1): 77–91.10.1111/irv.12670692805931568678
- 16. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX. Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine. 2020;382: 1708–1720.10.1056/NEJMoa2002032709281932109013
- 17. Government of India. Ministry of Health and Family Welfare (MOHFW). eSanjeevani- an Integrated Telemedicine Solution. Available from: https://esanjeevani.in/.
- 18. Government of India. Ministry of Health and Family Welfare (MOHFW). Accredited SocialHealthActivist(ASHA). Available from: https://nhm.gov.in/index1.php?lang1/41&level1/41&sublinkid1/4150&lid1/4226. [Accessed 7th April 2021].
- 19. ICMR approves use of diagnostic machine for drug resistant TB for COVID19. Available from: https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/icmrapproves-useof-diagnostic-machine-used-for-drug-resistant-tb-for-covid19/articleshow/75081319.cms?from1/4mdr. [Accessed 7th April 2021].